Related Experiment Video

Updated: Aug 11, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Impact of rheumatoid arthritis-associated HLA-DRbeta1 subtypes on protein kinase A signaling

Zhanguo Li1, Lei Han, Rulin Jia

  • 1Department of Rheumatology and Immunology, People's Hospital, Beijing University Medical School, Beijing 100034, China. zgli98@yahoo.com

Chinese Medical Journal
|July 24, 2003
PubMed

Insights

Rheumatoid arthritis (RA)-associated HLA-DRbeta1 subtypes influence the protein kinase A (PKA) pathway. Specific subtypes down-regulate PKA signaling, impacting RA pathogenesis.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is an autoimmune disease.
  • Specific HLA-DRbeta1 subtypes are associated with RA susceptibility.
  • The role of these subtypes in cellular signaling pathways remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of RA-associated HLA-DRbeta1 subtypes (* 0401, * 0402, * 0403, * 0404, and * 0101) on the protein kinase A (PKA) signaling pathway.
  • To elucidate the molecular mechanisms by which these HLA variants contribute to RA pathogenesis.

Main Methods:

  • Generation of transfectants expressing specific RA-associated HLA-DRbeta1 subtypes and their mutants.
  • Quantification of adenylate cyclase (AC) activity.
  • Measurement of cyclic adenosine monophosphate (cAMP) levels.
  • Assay of PKA activity in the generated transfectants.

Main Results:

  • Transfectants expressing HLA-DRbeta1 * 0401, * 0404, and * 0101 subtypes exhibited significantly lower levels of AC, cAMP, and PKA activity compared to those expressing HLA-DRbeta1 * 0402.
  • These findings suggest a differential impact of HLA-DRbeta1 subtypes on PKA signaling.

Conclusions:

  • RA-associated HLA-DRbeta1 molecules play a role in RA pathogenesis.
  • Down-regulation of the PKA signaling pathway by specific HLA-DRbeta1 subtypes is a potential mechanism contributing to RA development.
  • Targeting the PKA pathway may offer therapeutic strategies for RA.
Abstract

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...